-
Weight Loss
-
In Stock
GLP-1/GIP + Glycine Injection
GLP-1/GIP (tirzepatide) helps you feel full sooner and supports healthy blood sugar.
Glycine is a simple nutrient your body uses to build and repair tissues.
Together, they can help you manage hunger and support overall wellness.
Full-dose option: You can slowly increase your dose each month until you find the amount that works best for you, as directed by your care team.
Dose Increases Each Month
Dosage Options
Dosage prescribed is determined by the licensed provider based on medical judgment.
Prescription appetite suppression:
GLP-1/GIP + Glycine curbs appetite and reduces food cravings, promoting weight loss.
Scientifically backed weight loss aid:
GLP-1/GIP + Glycine is an effective weight loss aid, as demonstrated in clinical trials where some patients shed up to 15% of their body weight over 6-8 weeks.
Metabolic health booster:
GLP-1/GIP + B12 improves metabolic health by lowering blood sugar levels, improving insulin sensitivity, and decreasing the risk of health problems that often accompany obesity such as type 2 diabetes, high blood pressure, and cardiovascular disease.
Enhanced quality of life:
GLP-1/GIP + Glycine assists in reaching a healthy weight, which can reduce symptoms like fatigue and joint pain linked to excess weight. It also improves mobility and boosts energy levels.
A licensed provider will review within 48 hours.
Processing can take 2 – 10 business days (subject to pharmacy partners).
Once ready, shipping is via 2-day.
This product is prescribed by a licensed healthcare provider based on the individual needs. These statements and the product have not been evaluated or approved by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved, and their safety and efficacy have not been independently verified by the FDA. This information is provided for educational purposes only and should not be considered medical advice.
The Vivoro Experience
-
“★★★★★
Vivoro transformed my approach to wellness. The weight management program with GLP-1 therapy helped me lose 40 pounds while maintaining my busy lifestyle. The convenience and quality of care is unmatched.
-
“★★★★★
I had no idea whether to take the GLP-1 or the GLP-1/GIP. I called and they clearly walked me thru what the difference were and what request. The doctor has been great about answering a few questions I had after my meds came.
-
“★★★★★
I have the MTHFR gene mutation and being able to get this compounded with Glycine vs. B12 has been great.
-
“★★★★★
I love the ongoing support and how simple the program is to follow. It truly fits my lifestyle.
Frequently Asked Questions
Both GLP-1 + Glycine and GLP-1/GIP + Glycine are part of a group of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). They work by acting like a hormone called GLP-1, which helps control blood sugar levels. GLP-1/GIP + Glycine goes a step further by also mimicking another hormone called glucose-dependent insulinotropic polypeptide (GIP). Research has found that the combined effect of GLP-1 and GIP in GLP-1/GIP + Glycine is more effective for weight loss compared to GLP-1 + Glycine.
You need to be at least 18 years old.
You must reside in one of the states where our services are available or be physically present there.
It’s important to demonstrate the necessity for medical treatment. If requested by your healthcare provider, our team can assist you in obtaining recent lab results.
You must meet the FDA-approved criteria for these medications. This means having a body mass index (BMI) above 30 for individuals with obesity, or a BMI above 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol.
You should not have certain medical conditions, including type 1 diabetes, a history of chronic pancreatitis or pancreatitis caused by weight loss medications (GLP-1), severe gastrointestinal (GI) disease, current gallbladder problems (except for previous gallbladder removal), retinal impairment/diabetic retinopathy, recent bariatric surgery, multiple endocrine neoplasia syndrome type 2 (MEN-2), or a history of medullary thyroid cancer.
You should not be pregnant or nursing. Your healthcare provider affiliated with VIVORO will make the final decision regarding your eligibility for the weight loss program and may request additional information directly from you.
• People with Type 2 Diabetes:
GLP-1/GIP + Glycine's dual action on GIP and GLP-1 receptors can improve glycemic control by enhancing insulin secretion and reducing blood sugar levels, making it a promising option for those who need better diabetes management.
• Individuals Focused on Weight Management:
Clinical studies have demonstrated that GLP-1/GIP + Glycine can promote significant weight loss by curbing appetite and reducing caloric intake, which benefits people struggling with obesity or weight-related health challenges.
• Those with Metabolic Syndrome:
By addressing hyperglycemia, insulin resistance, and excess weight simultaneously, GLP-1/GIP + Glycine can support overall metabolic health, making it advantageous for individuals with metabolic syndrome.
• Patients with Cardiovascular Risk Factors:
Improved blood sugar regulation and weight loss can help reduce several cardiovascular risk factors, which is particularly beneficial for individuals with type 2 diabetes who are at an increased risk of heart disease.
• Individuals Seeking Comprehensive Metabolic Support:
For those looking to manage multiple facets of their metabolic health—ranging from blood sugar control to weight management—GLP-1/GIP + Glycine offers a multifaceted approach that may contribute to long-term overall well-being.